We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M Turnover 52.78%
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
+15.78%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$77.6M
Cap. Flow
-$471K
Cap. Flow %
-0.26%
Top 10 Hldgs %
77.6%
Holding
252
New
61
Increased
18
Reduced
33
Closed
72
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
0.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.75%
2 Financials 33.86%
3 Healthcare 7.1%
4 Technology 4%
5 Consumer Discretionary 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
C.WS.A icon
126
DELISTED
Citigroup Inc
C.WS.A
$11K 0.01%
75,000
– –
2013 Q2
14 quarters
PAACR icon
127
DELISTED
Pacific Special Acquisition Corp. Rights
PAACR
$8K ﹤0.01%
+14,400
New +$3.59K
2016 Q4
0 quarters
DRIOW icon
128
DELISTED
DarioHealth Corp. Warrant
DRIOW
$7K ﹤0.01%
10,000
– –
2016 Q3
1 quarter
IMNP
129
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$5K ﹤0.01%
1,250
– –
2014 Q3
9 quarters
ANDAR
130
DELISTED
Andina Acquisition Corp. II Right
ANDAR
$5K ﹤0.01%
12,500
– –
2016 Q2
2 quarters
SNGXW icon
131
DELISTED
Soligenix, Inc. Warrant
SNGXW
$4K ﹤0.01%
+12,500
New +$4.78K
2016 Q4
0 quarters
ANDAW
132
DELISTED
Andina Acquisition Corp. II Warrant
ANDAW
$3K ﹤0.01%
12,500
– –
2016 Q2
2 quarters
CVM.WS icon
133
DELISTED
Cel-Sci Corp Series S
CVM.WS
$2K ﹤0.01%
100,000
– –
2014 Q2
10 quarters
OPXAW
134
DELISTED
Opexa Therapeutics, Inc.
OPXAW
$1K ﹤0.01%
60,200
– –
2016 Q3
1 quarter
AAOI icon
135
Applied Optoelectronics
AAOI
$6.64B
– –
-15,000
Closed -$333K –
AGIO icon
136
Agios Pharmaceuticals
AGIO
$2.08B
– –
-15,000
Closed -$792K –
AMD icon
137
Advanced Micro Devices
AMD
$878B
– –
-25,000
Closed -$173K –
ARCO icon
138
Arcos Dorados Holdings
ARCO
$1.67B
– –
-23,126
Closed -$119K –
AVGO icon
139
Broadcom
AVGO
$1.6T
– –
-50,000
Closed -$863K –
BLMN icon
140
Bloomin' Brands
BLMN
$852M
– –
-10,000
Closed -$172K –
BXMT icon
141
Blackstone Mortgage Trust
BXMT
$1.73B
– –
-17,200
Closed -$507K –
CMG icon
142
CALL
Chipotle Mexican Grill
CMG
$37.8B
– –
-250,000
Closed -$2.12M –
COOP icon
143
DELISTED
Mr. Cooper
COOP
– –
-6,250
Closed -$176K –
CWST icon
144
Casella Waste Systems
CWST
$5.51B
– –
-20,000
Closed -$206K –
EXAS icon
145
CALL
DELISTED
Exact Sciences
EXAS
– –
-20,000
Closed -$371K –
EXEL icon
146
Exelixis
EXEL
$15.5B
– –
-10,000
Closed -$128K –
FCEL icon
147
FuelCell Energy
FCEL
$1.03B
– –
-28
Closed -$54K –
GSAT icon
148
Globalstar
GSAT
$10.8B
– –
-1,667
Closed -$30K –
IOVA icon
149
Iovance Biotherapeutics
IOVA
$6.44B
– –
-15,000
Closed -$123K –
ITUB icon
150
Itaú Unibanco
ITUB
$104B
– –
-22,676
Closed -$109K –

Similar funds

E.E. Geduld's Q4 2016 Portfolio in Review

As of Q4 2016, E.E. Geduld held 252 positions worth $178M, up 77% from $100M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

E.E. Geduld's Q4 2016 filing shows 61 new, 18 increased, 33 reduced and 72 closed positions. Its largest new stake was Salesforce: 25,000 shares worth $1.71M. The largest sale was Broadcom, an estimated $863K.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • E.E. Geduld's largest Q4 2016 buy was Salesforce: 25,000 shares worth $1.71M.
  • E.E. Geduld added most to Amazon in Q4 2016, an estimated $1.57M increase.
  • E.E. Geduld's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $778K.
  • E.E. Geduld fully exited Broadcom in Q4 2016, selling an estimated $863K.
  • E.E. Geduld's ten largest holdings make up 78% of its $178M portfolio in Q4 2016.
  • E.E. Geduld opened 61 new positions and closed 72 in Q4 2016.
  • E.E. Geduld's portfolio value rose 77% quarter-over-quarter to $178M.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.